Midwives Revision

ENT (Ear, Nose, Throat Conditions)

Atrophic Rhinitis

A chronic nasal condition characterized by progressive atrophy (thinning) of the nasal mucosa, submucosa, turbinate bones, and associated glands, leading to a widened nasal cavity filled with foul-smelling crusts.

Also known as: Ozena

View images for Atrophic Rhinitis (Google Images, opens in a new tab)
On this page

Referral and warning signs

When to refer

Refer to ENT Specialist (HC4/H/RR) if: Diagnosis uncertain. No improvement after 2 weeks of appropriate douching and antibiotics. Complications develop. Consideration for surgery.

Red flags

  • Suspicion of underlying malignancy or specific granulomatous disease.
  • Significant epistaxis.
  • Signs of orbital or intracranial extension (rare).

Signs and symptoms

  • Nasal obstruction sensation (despite wide airway).
  • Offensive nasal odour (Ozaena): Foul smell noticed by others, but usually NOT by the patient (due to anosmia).
  • Thick, dry crust formation in the nasal cavity (greenish, yellow, or black).
  • Epistaxis (nosebleeds) when crusts are removed.
  • Anosmia (loss of sense of smell).
  • Headache.
  • Examination: Widened nasal cavities, visible posterior pharyngeal wall, extensive crusting, atrophic pale mucosa, potential septal perforation.

Risk factors

  • Unknown cause (Primary Atrophic Rhinitis).
  • Secondary causes: Chronic infections (Klebsiella ozaenae sometimes implicated), Syphilis, Leprosy, Tuberculosis, Rhinoscleroma. Post-surgical changes (aggressive turbinectomy). Radiation therapy. Chronic granulomatous diseases. Nutritional deficiencies (possibly Iron, Vit A/D). Autoimmune factors.
  • Association with HIV/AIDS and poor socioeconomic status mentioned in UCG.

Diagnosis

Clinical assessment

Diagnosis based on characteristic clinical picture: wide nasal cavities, extensive crusting, foul odour (reported by others), and anosmia.

Investigations

  • Nasal Endoscopy (specialist).
  • CT Scan of Sinuses (shows bony atrophy, wide cavities).
  • Swab/Biopsy of crusts/mucosa: For Culture & Sensitivity (bacterial/fungal), Histology (rule out malignancy/granulomatous disease), AFB stain (TB), specific tests (syphilis, leprosy).
  • Consider VDRL/RPR (Syphilis), HIV test.

Diagnostic criteria

Clinical findings of nasal crusting, foul odour, anosmia, and wide nasal cavity on examination, supported by investigations ruling out other causes.

Differential diagnosis

  • Chronic Sinusitis (usually purulent discharge, not foul crusts/atrophy).
  • Nasal Tumour.
  • Chronic Granulomatous Disease (Wegener's, Sarcoidosis).
  • Fungal Sinusitis (allergic or invasive).
  • Rhinoscleroma (early stages mentioned in UCG).

Management

Non-pharmacological management

  • Nasal Douching/Irrigation (Mainstay): Regular, frequent (at least BID) nasal irrigation with large volumes of warm saline solution (e.g., Normal Saline 0.9%) or alkaline solution (e.g., Sodium Bicarbonate 5% - 1 tsp in 100ml warm water) to remove crusts and moisturize mucosa. (LOC: HC3)
  • Manual removal of crusts if necessary.
  • Humidification of inspired air.

Pharmacological treatment

  • Topical Lubrication/Moisturization: Application of lubricant ointment (e.g., Tetracycline eye ointment 1% per UCG, Vaseline) or paraffin oil inside the nose BID after douching to prevent crusting. (LOC: HC3)
  • Antibiotics (Target secondary infection, reduce odour/crusting):
  • - UCG recommends empirical Amoxicillin 500mg TID for 14 days. (LOC: HC3)
  • - Consider culture-directed therapy if specific organism identified.
  • - Rifampicin sometimes used (anti-Klebsiella effect).
  • - Prolonged courses may be needed.
  • Treat Underlying Cause: (e.g., Anti-TB meds, Syphilis treatment).
  • Glucose-in-glycerine drops (local preparation sometimes used).
  • Systemic medications (e.g., Potassium Iodide, vasodilators) - limited evidence, specialist use.

Monitoring

Monitor crusting, odour, patient comfort. Reinforce regular nasal douching. Follow up every 2 weeks initially.

Complications

  • Epistaxis.
  • Secondary infections (sinusitis, otitis media).
  • Septal perforation.
  • Pharyngitis sicca / Laryngitis sicca.
  • Social isolation due to odour.
  • Depression.

Prevention

  • Treat underlying infections (TB, Syphilis etc.).
  • Conservative nasal surgery (avoiding excessive turbinate removal).
  • Good nutrition.

Patient education

  • Explanation of the chronic nature of the condition.
  • Critical importance and technique of regular nasal douching/irrigation.
  • How to apply topical lubricants.
  • Need for long-term management.
  • Reassurance regarding anosmia (patient often unaware of odour).
  • Importance of treating secondary infections.

Uganda-specific notes

Condition seen, sometimes associated with specific infections or post-surgical changes. Nasal douching with saline/bicarbonate and topical lubrication are key practical measures. Access to specialist care/surgery limited.

Surgical Management

  • Procedures aim to narrow nasal cavity / reduce crusting (e.g., Young's operation, partial turbinectomy implants) - specialist procedures with variable success.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 21, Section 21.2.5

For learning and professional reference. Use current local guidance and clinical judgement.

Browse all conditions

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top